NL-OMON36334已完成不适用
Effect of Spinal Cord Stimulation in Painful Diabetic Polyneuropathy: a multicenter Randomised Controlled Trial (PDP study) - PDP study
Anesthesiologie-Pijnbestrijding0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Moderate-to-severe PDP in the lower limbs
- •o The pain intended to treat has been present for more than 12 months
- •o Previous treatment has been unsuccessful (insufficient pain relief and/or unacceptable side-effects) with drugs from the following drug categories:
- •* Amitriptylin or an other tricyclic antidepressant and/or
- •* Pregabalin (Lyrica®) or Gabapentin (Neurontin®) and/or
- •* Duloxetine (Cymbalta®) and/or
- •* Tramadol or strong opioids
- •Patients were treated with 3 drugs from the above mentioned drug categories and followed the treatment algorithm for painful diabetic polyneuropathy according to Jensen. Starting dosage was based on individual patient characteristics. Each drug was tried for at least 3 weeks and dose was raised once, if possible. By insufficient pain relief and/or unacceptable side-effects, the drug treatment was stopped. Patients reached a steady state in medication use and it is not allowed to increase dosage during the study. Use of opioids during the study is not allowed.
- •Mean pain intensity during daytime and/or night time should be 5 or higher measured on a numeric rating scale (NRS). Pain during daytime will be scored 3 times per day during for 4 days according to Jensen.
- •Patient*s age is between 18 and 80 years.
- •It is necessary that patients which use anti coagulation, especially coumarin derivatives, can stop for 10 days around the procedure. This will be authorized by the treating physician of the patient. There will be no bridging to heparin.
排除标准
- •The patient has had neuromodulation therapy during the month before the intake
- •Neuropathic pain is most prevalent in the upper limbs (NRS>3)
- •Neuropathy or chronic pain of other origin than diabetes mellitus (NRS> 3)
- •Use of opioids
- •Addiction: drugs, alcohol (> 5E / day) and/or medication
- •o Drugs: cocaine, heroine, marihuana.
- •o Alcohol: wine, beer, liquor (max 5E / day)
- •o Medication: benzodiazepines.
- •Insufficient cooperation from the patient (little motivation, understanding or communication)
- •Blood clotting disorder
- •Immune deficiency (HIV-positive, corticosteroids with a dose equivalent to > prednisolone 10 mg, immunodepressiva, etc.)
- •Peripheral vascular disease without palpable peripheral pulses at both feet (inclusion is possible if pulses are absent, but ankle brachial index is between 0.7 and 1.2 in both feet)
- •Active foot ulceration
- •Life expectancy < 1 year
- •Pacemaker
- •Local infection or other skin disorders at site of incision
- •Psychiatric problems potentially interfering with cooperation in the study
- •Pregnancy
- •Severe cardiac or pulmonary failure (> NYHA classification II)
- •Unstable blood glucose control (change in HbA1c>1,0% in three months prior to inclusion)
研究者
相似试验
已完成
不适用
Effect of Spinal Cord Stimulation in Painful Diabetic Polyneuropathy (PDP study) A pilot studyPain due to diabetic nerve damagepainful distal symmetrical diabetic polyneuropathy1001265310034606NL-OMON32639Academisch Ziekenhuis Maastricht20
已完成
不适用
Effect of Spinal Cord Stimulation in Painful Diabetic PolyneuropathyDiabetic NeuropathiesNCT00802022Maastricht University Medical Center15
Unknown
不适用
Effect of Spinal Cord Stimulation (SCS) in Painful Diabetic PolyneuropathyDiabetic NeuropathiesPainElectric Stimulation TherapyNCT01162993Maastricht University Medical Center40
招募中
Unknown
Compared conventional and new stimulation methods for intractable neuropathic paieuropathic painJPRN-jRCT1042220094Saito Ryuta92
招募中
不适用
The effect of spinal cord stimulation and dorsal root ganglion stimulation on histamine induced itch: an experimental pilot studyNL-OMON49164Erasmus MC, Universitair Medisch Centrum Rotterdam12